GPA33 and intestinal neoplasm: We have generated a new gpA33ΔN-Bcat knock-in mouse model to study intestinal tumor susceptibility by inserting the 1-131 amino-terminal truncation mutant of β-catenin into the 3′ UTR of the endogenous gpA33 antigen locus.